SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 50207
 
 
 
C07K PEPTIDES 23107
 
 
 
C07D HETEROCYCLIC COMPOUNDS 19134
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12151
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11184
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 7123
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 6117
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 546
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 487
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 364

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0066,731 SMALL MOLECULE FATTY ACID SYNTHASE INHIBITORSMar 05, 15Mar 09, 17[C07D]
2017/0036,987 Metabotropic Glutamate Receptor Positive Allosteric Modulators (PAMS) and Uses ThereofApr 06, 15Feb 09, 17[C07F, C07D, C07C]
2016/0355,479 SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORSAug 19, 16Dec 08, 16[C07D]
2016/0346,311 LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENTMar 31, 16Dec 01, 16[C12N, C12Q, A61K]
2016/0340,324 METHODS AND COMPOSITIONS FOR TREATING CANCERDec 22, 14Nov 24, 16[G06N, C07D, G06F, A61K]
2016/0340,744 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAApr 15, 16Nov 24, 16[C12N, C12Q, G01N]
2016/0232,293 DRUG SENSITIVITY BIOMARKERS AND METHODS OF IDENTIFYING AND USING DRUG SENSITIVITY BIOMARKERSOct 17, 14Aug 11, 16[G06F, G01N]
2016/0214,951 EBI2 MODULATORSSep 26, 14Jul 28, 16[C07F, C07D]
2016/0194,403 MODULATION OF GAMMA DELTA T CELLSSep 04, 14Jul 07, 16[C12N, G01N, C07K]
2016/0184,447 CAR Peptide for Homing, Diagnosis & Targeted Therapy for Pulmonary and Fibrotic DisordersNov 10, 15Jun 30, 16[C12Q, A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9610359 Methods and compositions related to annexin 1-binding compoundsDec 23, 10Apr 04, 17[A61P, A61K, C07K]
9611235 Methods and compositions related to a retinoid receptor-selective pathwayMay 06, 11Apr 04, 17[C07D, C07C, G01N, A61K]
9598402 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infectionsAug 10, 12Mar 21, 17[C07D, A61K]
9581598 Diagnosis and treatment of brain tumorApr 25, 13Feb 28, 17[C12N, G01N, A61K, C07K]
9546174 Inhibitor of apoptosis protein (IAP) antagonistsNov 26, 13Jan 17, 17[C07D]
9526693 Delivery of agents using interfering nanoparticlesMar 16, 11Dec 27, 16[C12N, A61K]
9522198 Methods and compositions related to targeting tumors and woundsJul 14, 14Dec 20, 16[A61K, C07K]
9458147 Sulfonamide compounds and uses as TNAP inhibitorsFeb 21, 13Oct 04, 16[C07D, A61K]
9410128 Method and compounds for generation of iPSCsFeb 22, 12Aug 09, 16[C12N, C07H, G01N]
9320810 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cellsOct 30, 13Apr 26, 16[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0022,831 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsABANMar 22, 15Jan 28, 16[A61K, C07K]
2015/0266,964 METHODS FOR ACCELERATING IMMUNE REGENERATIONABANOct 04, 13Sep 24, 15[C07K]
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESABANMar 14, 13Feb 19, 15[C07K]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYABANDec 17, 13Aug 28, 14[C12N, G01N]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAABANMar 15, 13May 15, 14[C12N, C12Q, A61K]
2014/0005,181 SMALL MOLECULE ANTAGONISTS OF THE APELIN RECEPTOR FOR THE TREATMENT OF DISEASEABANJun 20, 13Jan 02, 14[C07D]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USEABANSep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSABANNov 07, 12Aug 29, 13[C12Q, G01N]
2013/0210,124 DETERMINATION OF CANCER PREDISPOSITIONABANFeb 08, 13Aug 15, 13[G06F]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEABANDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISABANDec 02, 10Jun 20, 13[G01N]
2013/0136,786 LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENTABANFeb 09, 12May 30, 13[C12N, C12Q]
2013/0100,272 Multifunction autofocus system and method for automated microscopyABANOct 25, 11Apr 25, 13[H04N]
2013/0084,328 METHYLATED CODING AND NON-CODING RNA GENES AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR HUMAN MELANOMAABANApr 26, 12Apr 04, 13[C12Q]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGABANMay 31, 12Mar 14, 13[C12N, C40B, G01N, A61K]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESABANFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSABANOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0269,901 Methods and Compounds Useful to Induce Apoptosis in Cancer CellsABANDec 19, 11Oct 25, 12[A61P, G01N, A61K]
2012/0219,502 METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32ABANApr 17, 12Aug 30, 12[A61P, C12Q, A61K, G01N]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEABANDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.